{"id":1835,"date":"2016-03-11T00:00:00","date_gmt":"2016-03-10T23:00:00","guid":{"rendered":"https:\/\/emotra.lmimproveit.biz\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/"},"modified":"2016-03-11T00:00:00","modified_gmt":"2016-03-10T23:00:00","slug":"forsta-delen-av-kliniska-studien-ar-nu-genomford","status":"publish","type":"post","link":"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/","title":{"rendered":"F\u00f6rsta delen av kliniska studien \u00e4r nu genomf\u00f6rd"},"content":{"rendered":"<p>Emotra AB meddelar att testfasen i den p\u00e5g\u00e5ende kliniska multicenterstudien har avslutats. \u00d6ver 1\u00a0540 patienter har testats och analyserats. Den andra fasen inneb\u00e4r att patienterna ska f\u00f6ljas upp och kontrolleras under 12 m\u00e5nader. Den 10 mars 2017 kommer studien att vara helt avslutad.<\/p>\n<p><a href=\"https:\/\/emotra.se\/wp-content\/uploads\/2016\/03\/487710.pdf\">Release<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Emotra AB meddelar att testfasen i den p\u00e5g\u00e5ende kliniska multicenterstudien har avslutats. \u00d6ver 1\u00a0540 patienter har testats och analyserats. Den andra fasen inneb\u00e4r att patienterna ska f\u00f6ljas upp och kontrolleras under 12 m\u00e5nader. Den 10 mars 2017 kommer studien att vara helt avslutad. Release<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[21],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>F\u00f6rsta delen av kliniska studien \u00e4r nu genomf\u00f6rd - Emotra<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00f6rsta delen av kliniska studien \u00e4r nu genomf\u00f6rd - Emotra\" \/>\n<meta property=\"og:description\" content=\"Emotra AB meddelar att testfasen i den p\u00e5g\u00e5ende kliniska multicenterstudien har avslutats. \u00d6ver 1\u00a0540 patienter har testats och analyserats. Den andra fasen inneb\u00e4r att patienterna ska f\u00f6ljas upp och kontrolleras under 12 m\u00e5nader. Den 10 mars 2017 kommer studien att vara helt avslutad. Release\" \/>\n<meta property=\"og:url\" content=\"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/\" \/>\n<meta property=\"og:site_name\" content=\"Emotra\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-10T23:00:00+00:00\" \/>\n<meta name=\"author\" content=\"Claes Holmberg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Claes Holmberg\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/\",\"url\":\"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/\",\"name\":\"F\u00f6rsta delen av kliniska studien \u00e4r nu genomf\u00f6rd - Emotra\",\"isPartOf\":{\"@id\":\"https:\/\/emotra.se\/sv\/#website\"},\"datePublished\":\"2016-03-10T23:00:00+00:00\",\"dateModified\":\"2016-03-10T23:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/emotra.se\/sv\/#\/schema\/person\/30edd435223789be0cddcf7aa41be5c1\"},\"breadcrumb\":{\"@id\":\"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/emotra.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00f6rsta delen av kliniska studien \u00e4r nu genomf\u00f6rd\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/emotra.se\/sv\/#website\",\"url\":\"https:\/\/emotra.se\/sv\/\",\"name\":\"Emotra\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/emotra.se\/sv\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/emotra.se\/sv\/#\/schema\/person\/30edd435223789be0cddcf7aa41be5c1\",\"name\":\"Claes Holmberg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/emotra.se\/sv\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/be640240368a444c43f88f43f90a87a6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/be640240368a444c43f88f43f90a87a6?s=96&d=mm&r=g\",\"caption\":\"Claes Holmberg\"},\"url\":\"https:\/\/emotra.se\/sv\/author\/claes\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00f6rsta delen av kliniska studien \u00e4r nu genomf\u00f6rd - Emotra","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/","og_locale":"sv_SE","og_type":"article","og_title":"F\u00f6rsta delen av kliniska studien \u00e4r nu genomf\u00f6rd - Emotra","og_description":"Emotra AB meddelar att testfasen i den p\u00e5g\u00e5ende kliniska multicenterstudien har avslutats. \u00d6ver 1\u00a0540 patienter har testats och analyserats. Den andra fasen inneb\u00e4r att patienterna ska f\u00f6ljas upp och kontrolleras under 12 m\u00e5nader. Den 10 mars 2017 kommer studien att vara helt avslutad. Release","og_url":"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/","og_site_name":"Emotra","article_published_time":"2016-03-10T23:00:00+00:00","author":"Claes Holmberg","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"Claes Holmberg"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/","url":"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/","name":"F\u00f6rsta delen av kliniska studien \u00e4r nu genomf\u00f6rd - Emotra","isPartOf":{"@id":"https:\/\/emotra.se\/sv\/#website"},"datePublished":"2016-03-10T23:00:00+00:00","dateModified":"2016-03-10T23:00:00+00:00","author":{"@id":"https:\/\/emotra.se\/sv\/#\/schema\/person\/30edd435223789be0cddcf7aa41be5c1"},"breadcrumb":{"@id":"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/emotra.se\/sv\/forsta-delen-av-kliniska-studien-ar-nu-genomford\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/emotra.se\/sv\/"},{"@type":"ListItem","position":2,"name":"F\u00f6rsta delen av kliniska studien \u00e4r nu genomf\u00f6rd"}]},{"@type":"WebSite","@id":"https:\/\/emotra.se\/sv\/#website","url":"https:\/\/emotra.se\/sv\/","name":"Emotra","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/emotra.se\/sv\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sv-SE"},{"@type":"Person","@id":"https:\/\/emotra.se\/sv\/#\/schema\/person\/30edd435223789be0cddcf7aa41be5c1","name":"Claes Holmberg","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/emotra.se\/sv\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/be640240368a444c43f88f43f90a87a6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/be640240368a444c43f88f43f90a87a6?s=96&d=mm&r=g","caption":"Claes Holmberg"},"url":"https:\/\/emotra.se\/sv\/author\/claes\/"}]}},"_links":{"self":[{"href":"https:\/\/emotra.se\/sv\/wp-json\/wp\/v2\/posts\/1835"}],"collection":[{"href":"https:\/\/emotra.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/emotra.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/emotra.se\/sv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/emotra.se\/sv\/wp-json\/wp\/v2\/comments?post=1835"}],"version-history":[{"count":0,"href":"https:\/\/emotra.se\/sv\/wp-json\/wp\/v2\/posts\/1835\/revisions"}],"wp:attachment":[{"href":"https:\/\/emotra.se\/sv\/wp-json\/wp\/v2\/media?parent=1835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/emotra.se\/sv\/wp-json\/wp\/v2\/categories?post=1835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/emotra.se\/sv\/wp-json\/wp\/v2\/tags?post=1835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}